Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Larkin, J. et al. Combined Nivolumab and Ipilimumab or Monotherapy in Previously Untreated Melanoma. N. Engl. J. Med. 373, 23–34 (2015).
2. Gibney, G. T., Weiner, L. M. & Atkins, M. B. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet Oncol. 17, e542–e551 (2016).
3. Teixidó, C., González-Cao, M., Karachaliou, N. & Rosell, R. Predictive factors for immunotherapy in melanoma. Ann. Transl. Med. 3, 208 (2015).
4. Ladányi, A. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma. Pigment Cell Melanoma Res. 28, 490–500 (2015).
5. Espinosa, E. et al. Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM). Ann. Transl. Med. 5, 389 (2017).
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献